I agree that this site is using cookies. You can find further informations here.
X
du Rusquec, Pauline
~ 0  results:
Search for persons X
?
1

Accelerated subsequent lung cancer after post-operative rad..:

Basse, Clémence ; Ancel, Julien ; Massiani, Marie-Ange...
Lung Cancer.  182 (2023)  - p. 107295 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Outcome of adrenocortical carcinoma patients included in ea..:

Hescot, Ségolène ; Debien, Véronique ; Hadoux, Julien...
European Journal of Cancer.  189 (2023)  - p. 112917 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Significant response to pralsetinib in a medullary thyroid ..:

Hescot, Ségolène ; Masliah-Planchon, Julien ; du Rusquec, Pauline...
European Thyroid Journal.  11 (2022)  5 - p. , 2022
Link: https://doi.org/10.1530/..
 
?
4

A computational method for prioritizing targeted therapies ..:

Petak, Istvan ; Kamal, Maud ; Dirner, Anna...
npj Precision Oncology.  5 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Drug Development in Tissue-Agnostic Indications:

du Rusquec, Pauline ; Le Tourneau, Christophe
Cancers.  13 (2021)  11 - p. 2758 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Risks and benefits of anticancer drugs in advanced cancer p..:

Moreau Bachelard, Camille ; Coquan, Elodie ; du Rusquec, Pauline..
EClinicalMedicine.  40 (2021)  - p. 101130 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Current Clinical Evidence and Potential Solutions to Increa..:

Alcantara, Marion ; Du Rusquec, Pauline ; Romano, Emanuela
OncoImmunology.  9 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
8

Pseudoprogression and Hyperprogression as New Forms of Resp..:

Frelaut, Maxime ; du Rusquec, Pauline ; de Moura, Alexandre..
BioDrugs.  34 (2020)  4 - p. 463-476 , 2020
Link: https://doi.org/10.1007/..
 
?
9

Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor po..:

du Rusquec, Pauline ; Blonz, Cyriac ; Frenel, Jean Sebastien.
Therapeutic Advances in Medical Oncology.  12 (2020)  - p. 175883592094093 , 2020
Link: https://doi.org/10.1177/..
 
?
10

Fine‐needle aspiration as an alternative to core needle bio..:

Dupain, Célia ; Masliah‐Planchon, Julien ; Gu, Céline...
Molecular Oncology.  15 (2020)  1 - p. 104-115 , 2020
Link: https://doi.org/10.1002/..
 
?
11

Clinical utility of pembrolizumab in the management of adva..:

du Rusquec, Pauline ; de Calbiac, Ombline ; Robert, Marie..
Cancer Management and Research.  11 (2019)  - p. 4297-4312 , 2019
Link: https://doi.org/10.2147/..
 
?
12

Worsening and newly diagnosed paraneoplastic syndromes foll..:

Manson, Guillaume ; Maria, Alexandre Thibault Jacques ; Poizeau, Florence...
Journal for ImmunoTherapy of Cancer.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
13

Efficacy of palbociclib plus fulvestrant after everolimus i..:

du Rusquec, Pauline ; Palpacuer, Clément ; Campion, Loic...
Breast Cancer Research and Treatment.  168 (2017)  2 - p. 559-566 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Totally implantable venous access ports: a prospective long..:

Voog, Eric ; Campion, Loïc ; du Rusquec, Pauline...
Supportive Care in Cancer.  26 (2017)  1 - p. 81-89 , 2017
Link: https://doi.org/10.1007/..
 
?
15

Significant response to pralsetinib in a medullary thyroid ..:

Hescot, Ségolène ; Masliah-Planchon, Julien ; du Rusquec, Pauline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578058/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15